IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

Use an existing password
Company dossier

Goldline Pharmaceutical

BSE:GLPL · ISIN INE1CLW01015

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Goldline Pharmaceutical

Filings

Preserved evidence

Primary-source filing timeline

11 recent events
Goldline Pharmaceutical Ltd - 544759 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Goldline Pharmaceutical Ltd - 544759 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing
Goldline Pharmaceutical Ltd - 544759 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing
Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing
Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing
Goldline Pharmaceutical Ltd - 544759 - Disclosure Under Regulation 29 (2) Of Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011BSE · exchange filing · pdf
Source filing
Goldline Pharmaceutical Ltd - 544759 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing
Goldline Pharmaceutical Ltd - 544759 - Board Meeting Outcome for Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026BSE · financial results · pdf
Source filing
Goldline Pharmaceutical Ltd - 544759 - Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026BSE · financial results · pdf
Source filing
Goldline Pharmaceutical Ltd - 544759 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 To Be Held On Tuesday, June 09, 2026.BSE · exchange filing · pdf
Source filing
Goldline Pharmaceutical Ltd - 544759 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing